SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000929638-23-001329
Filing Date
2023-05-01
Accepted
2023-05-01 16:23:40
Documents
2
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT, LPCORMORANT GLOBAL HEALTHCARE GP, LLC

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G/A 83297
2 exhibit99-1.htm EX-99.1 12766
  Complete submission text file 0000929638-23-001329.txt   97922
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81613 | Film No.: 23874038
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Filed by) CIK: 0001618442 (see all company filings)

IRS No.: 981101801 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A